St. Luke's Cancer Center - Allentown Campus — Allentown, Pennsylvania

St. Luke's Cancer Center - Allentown Campus is a clinical research site located in Allentown, Pennsylvania, United States 18104.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

St. Luke's Cancer Center - Allentown Campus has participated in 2 clinical trials.

Therapeutic areas: BRAF or NRAS Mutant Metastatic Melanoma, Metastatic or Unresectable Cutaneous Melanoma.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cancer Center - Allentown Campus?

St. Luke's Cancer Center - Allentown Campus has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cancer Center - Allentown Campus conducted?

St. Luke's Cancer Center - Allentown Campus has 2 clinical trials on record. Their work covers BRAF or NRAS Mutant Metastatic Melanoma, Metastatic or Unresectable Cutaneous Melanoma.

Is St. Luke's Cancer Center - Allentown Campus accredited by Crixeo Health?

St. Luke's Cancer Center - Allentown Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Cancer Center - Allentown Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.